Nurse Practitioner · Fort Wayne, IN
NPI
1346682234
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11104 Parkview Circle Dr, Suite 310
Fort Wayne, IN, 46845
Phone (260) 266-5230
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
190 services
Medicare patients, 2024
118
Average age 69
Drug cost, 2024
$5.8M
1,069 prescriptions
Company payments, 2025
$2,549
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacey E Elwood was code 99214 (office e&m - established), 124 times for 81 patients. In total Stacey E Elwood billed 190 services in 5 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 124 | 81 | $58.93 | $7,307 |
| 99214 Office E&M - Established | Office | 41 | 30 | $66.17 | $2,713 |
By year: 2022 $20K for 249 services; 2023 $15K for 228 services; 2024 $11K for 190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stacey E Elwood prescribed most often to Medicare patients was Stelara (Ustekinumab), with 161 prescriptions and refills. In total Stacey E Elwood wrote 1,069 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 161 | 191 | 32 | $4.2M |
| Omeprazole Generic | 133 | 331 | 50 | $1,586 |
| Pantoprazole Sodium Generic | 112 | 260 | 48 | $1,565 |
| Famotidine Generic | 103 | 253 | 36 | $2,231 |
| Skyrizi On-Body Risankizumab-Rzaa | 51 | 62 | Under 11 | $1.0M |
| Mesalamine Generic | 48 | 84 | 18 | $16K |
| Humira(Cf) Pen Adalimumab | 34 | 39 | Under 11 | $325K |
| Prednisone Generic | 31 | 39 | 23 | $189 |
| Lansoprazole Generic | 26 | 36 | Under 11 | $719 |
| Dicyclomine Hcl Generic | 24 | 26 | 12 | $474 |
| Budesonide Dr Budesonide | 21 | 27 | 14 | $3,057 |
| Budesonide Er Budesonide | 18 | 18 | Under 11 | $19K |
| Xifaxan Rifaximin | 18 | 18 | Under 11 | $53K |
| Mesalamine Dr Mesalamine | 17 | 39 | Under 11 | $12K |
| Loperamide Loperamide Hcl | 16 | 24 | Under 11 | $583 |
Brand drugs: 368 claims; generic drugs: 701 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacey E Elwood $2,549 ($2,549 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $826.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 24 | $826 |
| Abbvie Inc. ABBV | 50 | $743 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 21 | $405 |
| Lilly USA, LLC LLY | 2 | $114 |
| QOL Medical, LLC | 6 | $100 |
| Madrigal Pharmaceuticals MDGL | 2 | $82.96 |
| Ardelyx, Inc. ARDX | 4 | $72.61 |
| Gilead Sciences, Inc. GILD | 2 | $43.53 |
| Genzyme Corporation SNY | 2 | $43.28 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $41.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.